GlassScriptPhysician profile
Joshua A Wilson
NPI 1861848939
$40,024.50
in general payments reported to CMS, 2019-2025
14 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,534 · 2020: $1,329 · 2021: $19K · 2022: $7,831 · 2023: $3,477 · 2024: $815 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,164 · Travel and Lodging: $1,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,164.43 |
| Travel and Lodging | $1,557.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $16,455.68 | 2021-2022 | |
| Pylant Medical | $11,305.98 | 2019-2023 | |
| Smith+Nephew, INC. | $5,653.94 | 2019-2025 | Fast-Fix, Spatial Frame, Q-Fix |
| Stryker Corporation | $2,797.06 | 2021-2025 | Mako, Accolade, Reunion |
| Alon Medical Technology | $2,400.00 | 2021 | |
| Depuy Synthes Sales INC. | $299.88 | 2022-2025 | Na |
| Medical Device Business Services, INC. | $284.98 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $265.11 | 2021-2024 | Rosa |
| Tenex Health INC. | $146.36 | 2021 | |
| Pacira Therapeutics, INC. | $125.02 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $124.69 | 2022 | |
| Vericel Corporation | $114.48 | 2022 | |
| Medacta USA, INC. | $28.65 | 2024 | |
| Innovation Technologies INC | $22.67 | 2025 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.